Cargando…

Modulatory Effects of Pregnancy on Inflammatory Bowel Disease

The disease course of autoimmune diseases such as rheumatoid arthritis is altered during pregnancy, and a similar modulatory role of pregnancy on inflammatory bowel disease (IBD) has been proposed. Hormonal, immunological, and microbial changes occurring during normal pregnancy may interact with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Giessen, Janine, Huang, Vivian W., van der Woude, C. Janneke, Fuhler, Gwenny M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445610/ https://www.ncbi.nlm.nih.gov/pubmed/30908306 http://dx.doi.org/10.14309/ctg.0000000000000009

Ejemplares similares

A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019)

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
por: Lie, Mitchell R. K. L., et al.
Publicado: (2018)

Modulation of cytokine patterns and microbiome during pregnancy in IBD
por: van der Giessen, Janine, et al.
Publicado: (2020)

The impact of biologics on health-related quality of life in patients with inflammatory bowel disease
por: Vogelaar, Lauran, et al.
Publicado: (2009)

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021)

Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events
por: Lie, Mitchell R. K. L., et al.
Publicado: (2020)

Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease
por: Somasundaram, Rajesh, et al.
Publicado: (2013)

Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease
por: Nuij, V. J. A. A., et al.
Publicado: (2017)

Inflammatory bowel disease negatively impacts household and family life
por: Paulides, Emma, et al.
Publicado: (2021)

Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases
por: Bunt, Daan V., et al.
Publicado: (2021)

Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation
por: Sleutjes, Jasmijn A M, et al.
Publicado: (2022)

Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study
por: van den Brink, Gertrude, et al.
Publicado: (2019)

Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease
por: van Linschoten, Reinier Cornelis Anthonius, et al.
Publicado: (2023)

Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents
por: van Linschoten, Reinier Cornelis Anthonius, et al.
Publicado: (2021)

Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease
por: Paulides, Emma, et al.
Publicado: (2021)

Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters
por: Vogelaar, Lauran, et al.
Publicado: (2017)

Analysis of SHIP1 expression and activity in Crohn’s disease patients
por: Somasundaram, Rajesh, et al.
Publicado: (2017)

Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases
por: Imamdin, Aqeela, et al.
Publicado: (2023)

Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice
por: Proietti, Elisa, et al.
Publicado: (2023)

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
por: Deuring, J. Jasper, et al.
Publicado: (2019)

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey
por: Baars, J. E., et al.
Publicado: (2012)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Drug Discovery in Liver Disease Using Kinome Profiling
por: Yu, Bingting, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: van de Pol, Natasja, et al.
Publicado: (2023)

Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
por: Qu, Changbo, et al.
Publicado: (2021)

High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23
por: Dahlerup, Jens Frederik, et al.
Publicado: (2016)

To Understand the Modulatory Effect of Probiotics on Irritable Bowel Syndrome
por: Yuan, Anlong, et al.
Publicado: (2018)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome
por: Hoekstra, Elmer, et al.
Publicado: (2016)

Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case–control study
por: Gerrits, Monique M., et al.
Publicado: (2011)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
por: Pauwels, Renske W. M., et al.
Publicado: (2020)

Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
por: De Lima-Karagiannis, A, et al.
Publicado: (2020)

Knowledge translation dataset: An e-health intervention for pregnancy in inflammatory bowel disease
por: Sutton, Reed T., et al.
Publicado: (2018)

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
por: Crouwel, Femke, et al.
Publicado: (2022)

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
por: van der Valk, Mirthe E., et al.
Publicado: (2016)

Insights into the treatment of inflammatory bowel disease in pregnancy
por: Shannahan, Sarah E., et al.
Publicado: (2019)

Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial
por: van den Brink, Gertrude, et al.
Publicado: (2019)

Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction
por: Proietti, Elisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kvmc3fic8hcrrggluvblm8br40